Beta Drugs fundamental analysis
BETA
1689.95
19.75 (1.18%)Last updated on 10 Nov, 2025 | 13:23 IST
BUYSELL
The current prices are delayed, login to your account for live prices
LoginBeta Drugs Fundamentals
P/E Ratio
39.75
P/B Ratio
8.55
Div. Yield
0
Sector P/E
36.99
Sector P/B
3.63
Sec. Div. Yield
0.56
- Beta Drugs Fundamentals is currently trading with a P/E Ratio of 39.75, compared to the sector average of 36.99. Its P/B Ratio stands at 8.55, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Beta Drugs Score Card
Price
Attractive
Growth
Good
Quality
Good
Management
Good
- On its scorecard, Beta Drugs reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.